Lipid-lowering therapy with statins in high-risk elderly patients: the treatment-risk paradox
Ko DT, Mamdani M, Alter DA. JAMA. 2004; 291(15):1864-70.
Publications
Neuroleptic drug therapy in older adults newly admitted to nursing homes: incidence, dose and specialist contact
Bronskill SE, Anderson GM, Sykora K, Wodchis WP, Gill S, Shulman KI, Rochon PA. J Am Geriatr Soc. 2004; 52(5):749-55.
Drug-induced lithium toxicity in the elderly: a population-based study
Juurlink DN, Mamdani MM, Kopp A, Rochon PA, Shulman KI, Redelmeier DA. J Am Geriatr Soc. 2004; 52(5):794-8.
Safety of glycoprotein IIb/IIIa inhibitors in urgent or emergency coronary artery bypass graft surgery
Cheng DK, Jackevicius CA, Seidelin P, Feindel C, Rouleau JL. Can J Cardiol. 2004; 20(2):223-8.
Changes in prescribing patterns following publication of the ALLHAT trial
Austin PC, Mamdani MM, Tu K, Zwarenstein M. JAMA. 2004; 291(1):44-5.
Avoiding drug interactions in hospitalized patients
Juurlink D, Mamdani M, Iazzetta J, Etchells E. Healthc Q. 2004; 7(2):27-8.
Trends in cardiovascular drug utilization and drug expenditures in Canada between 1996 and 2001
Jackevicius CA, Tu K, Filate WA, Brien SE, Tu JV; Canadian Cardiovascular Outcomes Research Team. Can J Cardiol. 2003; 19(12):1359-66.
Rising to the challenge: transforming the treatment of ST-segment elevation myocardial infarction
Ghali WA, Donaldson CR, Knudtson ML, Lewis SJ, Maxwell CJ, Tu JV. CMAJ. 2003; 169(1):35-7.
Should low-molecular-weight heparin be used in the treatment of acute coronary syndromes in rural hospitals?
Manuel DG, Knight CA, Mamdani M. Can J Rural Med. 2003; 8(3):173-8.
Association between ACE inhibitors and acute pancreatitis in the elderly
Cheng RM, Mamdani M, Jackevicius CA, Tu K. Ann Pharmacother. 2003; 37(7-8):994-8.